Author:

CHDS’ affiliated faculty Myriam Hunink directs the Netherlands Institute for Health Sciences (NIHES), an international academic research institute that is part of the Erasmus University

The COVID-19 crisis has focused unprecedented attention on the use of benefit-cost analysis and approaches for valuing mortality risk reductions, commonly referred to as the

The Society for Risk Analysis recently featured a webinar, “Valuing Statistical Lives: Concepts, Current Practices, and Challenges,” led by CHDS researcher Lisa A. Robinson.

CHDS, in conjunction with the Harvard Center for Risk Analysis (HCRA), hosted a seminar by Neal Fann from the U.S. Environmental Protection Agency (EPA) on Air Pollution and Population Growth.

CHDS hosted a seminar with Matthew Robson, PhD, Postdoctoral Researcher in Economics at University of York. The seminar was on “Differential Effects of the Smoking Ban in England.”

CHDS hosted a seminar with Shaun Forbes, PhD Candidate in Health Services Research at the Brown University School of Public Health, on “Propagating Ambiguity into Mathematical Models

CHDS faculty Lisa A. Robinson and James K. Hammitt, and research staff Lucy O’Keeffe, recently published “Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis.”

The CHDS Media Hub team continues its ongoing mission to improve multi-modal pedagogy across the Harvard Chan School through a new partnership between Media Hub Director Jacob Waxman

Natalia Kunst, PhD candidate at the University of Oslo, presented a CHDS lunchtime seminar on “What is the Value of Further Research on the 21-Gene Assay for Breast Cancer Management”.

The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center announces its call for submissions for the inaugural CEVR Cost-Effectiveness Analysis (CEA)